Annual revenue rose from KRW 561 billion in 2022 to KRW 679.5 billion in 2023 (up 21.1% year on year), KRW 735.9 billion in 2024 (up 8.3%) and KRW 785.9 billion in 2025 (up 6.8%), and it has increased three years in a row since 2023.
Operating profit rose from KRW 19.4 billion in 2022 to KRW 45.4 billion in 2025 (up 21.0% year on year), increasing three years in a row since 2023. The operating margin climbed from 3.5% in 2022 to 5.8% in 2025, so profitability improved alongside sales growth.
Net profit attributable to controlling shareholders rose from KRW 9.35 billion in 2022 to KRW 30.5 billion in 2023 (up 226.7%), KRW 35.1 billion in 2024 and KRW 43.9 billion in 2025 (up 25.0%). Net profit including non-controlling interests, a different figure, was KRW 44.3 billion in 2025.
The debt ratio fell from 164.7% in 2022 to 95.9% in 2025. At the end of 2025, total equity was KRW 267 billion, of which KRW 260.5 billion belonged to controlling shareholders, and total liabilities were KRW 256.1 billion. Operating cash flow rose from KRW 48.7 billion in 2022 to KRW 69.2 billion in 2025.
Quarterly operating profit fell to KRW 5.4 billion in the fourth quarter of 2025, down 57.5% from the prior quarter, then rose to KRW 11.8 billion, KRW 15.2 billion and KRW 16.9 billion in the first three quarters of 2026. Third-quarter 2026 revenue was KRW 209 billion, up 10.4% year on year.
In the first half of 2026, operating profit was KRW 27.0 billion, down 1%, and the operating margin was 6.3%, down 0.6 percentage points, with the China unit's sales decline and domestic research building costs as the main factors.
Net profit attributable to controlling shareholders in the third quarter of 2026 was KRW 6.42 billion, down 47.8% from the prior quarter and down 48.1% year on year, so operating profit and net profit moved in different directions.
The sum of net profit attributable to controlling shareholders over the last four quarters was KRW 35.8 billion. Factors cited for the second-half recovery include deferred mold sales revenue from the first half and the absence of last year's one-time costs.